.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Prof. Dr. Michael Schindler

Tuebingen / DE

University Hospital Tuebingen

Weitere Beteiligungen

28.03.2023
Poster
P 155
The tetraspanin CD81 restricts EBOV replication and is antagonized by the viral glycoprotein and VP40
Host cell factors and modulation, Virus receptors and entry
28.03.2023
Poster
P 108
Characterization of C10 – a broadly acting flavivirus capsid inhibitor
Emerging viruses and zoonosis
28.03.2023
Poster
P 356
Beyond entry – additional roles of CD81 in the life cycle of HCV
Viral replication strategies 1 (RNA viruses)
28.03.2023
Poster
P 030
Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs
Antiviral therapy and resistance, SARS-CoV-2
28.03.2023
Poster
P 031
Regulation of SAMHD1 upon HCMV infection and potential of CDK4/6 inhibitors to suppress HCMV replication in macrophages
Antiviral therapy and resistance, Host cell factors and modulation
28.03.2023
Poster
P 203
SARS-CoV-2 spike and orf7a downregulate the host restriction factor BST2/tetherin
Innate immunity, SARS-CoV-2
28.03.2023
Poster
P 035
Effects of SARS-CoV-2 infection on GSK3 phosphorylation and the use of specific GSK3 inhibitors as antivirals
Antiviral therapy and resistance, SARS-CoV-2
28.03.2023
Poster
P 053
Replication of primary HIV-1 strains in macrophages and virus transmission to T cells
Antiviral therapy and resistance, Viral pathogenesis and persistence
28.03.2023
Poster
P 172
Vpr enhances HIV-1 replication by activation of NFAT and degradation of specific host cell factors
Host cell factors and modulation, Innate immunity
29.03.2023
10:45 – 11:00 12 Min. 3 Min.
Abstract Talk
O 044
Identification of new cellular target proteins of HIV-1 Vpu and Vpr using ubiquitinome profiling
Adaptive immunity
30.03.2023
14:30 – 14:45 12 Min. 3 Min.
Abstract Talk
O 095
HIV-1 accessory proteins Nef and Vpu downregulate CD96 (TACTILE) from the surface of infected primary human CD4+ T cells
Host cell factors and modulation, Viral pathogenesis and persistence
31.03.2023
12:00 – 12:15 12 Min. 3 Min.
Abstract Talk
O 120
Immune suppression of vaccine-induced CD8⁺ T-cell responses by gamma retrovirus envelope is mediated by interleukin-10-producing CD4⁺ T cells
Adaptive immunity, Vaccines